Telomerase reverse transcriptase (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Telomerase reverse transcriptase" in English language version.

refsWebsite

Global rank English rank

78nih.gov

4^th place

50doi.org

2^nd place

12semanticscholar.org

11^th place

8^th place

8harvard.edu

18^th place

17^th place

3handle.net

102^nd place

76^th place

2ensembl.org

1,626^th place

1,007^th place

1nii.ac.jp

304^th place

1,952^nd place

doi.org (Global: 2^nd place; English: 2^nd place)

Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. (December 1997). "Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT". Nature Genetics. 17 (4): 498–502. doi:10.1038/ng1297-498. PMID 9398860. S2CID 2558116.
Kirkpatrick KL, Mokbel K (December 2001). "The significance of human telomerase reverse transcriptase (hTERT) in cancer". European Journal of Surgical Oncology. 27 (8): 754–60. doi:10.1053/ejso.2001.1151. PMID 11735173.
Shampay J, Blackburn EH (January 1988). "Generation of telomere-length heterogeneity in Saccharomyces cerevisiae". Proceedings of the National Academy of Sciences of the United States of America. 85 (2): 534–8. Bibcode:1988PNAS...85..534S. doi:10.1073/pnas.85.2.534. PMC 279585. PMID 3277178.
Poole JC, Andrews LG, Tollefsbol TO (May 2001). "Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)". Gene. 269 (1–2): 1–12. doi:10.1016/S0378-1119(01)00440-1. PMID 11376932.
Zhang A, Zheng C, Hou M, Lindvall C, Li KJ, Erlandsson F, et al. (April 2003). "Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome". American Journal of Human Genetics. 72 (4): 940–8. doi:10.1086/374565. PMC 1180356. PMID 12629597.
Cerruti Mainardi P (September 2006). "Cri du Chat syndrome". Orphanet Journal of Rare Diseases. 1: 33. doi:10.1186/1750-1172-1-33. PMC 1574300. PMID 16953888.
Cong YS, Wen J, Bacchetti S (January 1999). "The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter". Human Molecular Genetics. 8 (1): 137–42. doi:10.1093/hmg/8.1.137. PMID 9887342.
Bryce LA, Morrison N, Hoare SF, Muir S, Keith WN (2000). "Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization". Neoplasia. 2 (3): 197–201. doi:10.1038/sj.neo.7900092. PMC 1507564. PMID 10935505.
Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I (2008). "Telomerase regulation at the crossroads of cell fate". Cytogenetic and Genome Research. 122 (3–4): 263–72. doi:10.1159/000167812. PMID 19188695. S2CID 46652078.
Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.
Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, et al. (February 2009). "Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells". Cell Stem Cell. 4 (2): 141–54. doi:10.1016/j.stem.2008.12.010. PMID 19200803.
Walne AJ, Dokal I (April 2009). "Advances in the understanding of dyskeratosis congenita". British Journal of Haematology. 145 (2): 164–72. doi:10.1111/j.1365-2141.2009.07598.x. PMC 2882229. PMID 19208095.
Flores I, Benetti R, Blasco MA (June 2006). "Telomerase regulation and stem cell behaviour". Current Opinion in Cell Biology. 18 (3): 254–60. doi:10.1016/j.ceb.2006.03.003. PMID 16617011.
Calado R, Young N (2012). "Telomeres in disease". F1000 Medicine Reports. 4: 8. doi:10.3410/M4-8. PMC 3318193. PMID 22500192.
Flores I, Blasco MA (September 2010). "The role of telomeres and telomerase in stem cell aging". FEBS Letters. 584 (17): 3826–30. doi:10.1016/j.febslet.2010.07.042. PMID 20674573. S2CID 22993253.
Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT, Hung SC (July 2010). "Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines". Journal of Biomedical Science. 17 (1): 64. doi:10.1186/1423-0127-17-64. PMC 2923118. PMID 20670406.
Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, et al. (April 2006). "hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis". Cancer Research. 66 (7): 3531–40. doi:10.1158/0008-5472.CAN-05-2183. PMID 16585177.
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. (January 1998). "Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas". Nature Genetics. 18 (1): 65–8. doi:10.1038/ng0198-65. PMID 9425903. S2CID 8856414.
Baird DM (May 2010). "Variation at the TERT locus and predisposition for cancer". Expert Reviews in Molecular Medicine. 12: e16. doi:10.1017/S146239941000147X. PMID 20478107. S2CID 13727556.
McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. (December 2008). "Lung cancer susceptibility locus at 5p15.33". Nature Genetics. 40 (12): 1404–6. doi:10.1038/ng.254. PMC 2748187. PMID 18978790.
Sundin T, Hentosh P (March 2012). "InTERTesting association between telomerase, mTOR and phytochemicals". Expert Reviews in Molecular Medicine. 14: e8. doi:10.1017/erm.2012.1. PMID 22455872. S2CID 8076416.
Zhang X, Mar V, Zhou W, Harrington L, Robinson MO (September 1999). "Telomere shortening and apoptosis in telomerase-inhibited human tumor cells". Genes & Development. 13 (18): 2388–99. doi:10.1101/gad.13.18.2388. PMC 317024. PMID 10500096.
Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. (June 2012). "Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis". Journal of the National Cancer Institute. 104 (11): 840–54. doi:10.1093/jnci/djs222. PMC 3611810. PMID 22523397.
Glukhov AI, Svinareva LV, Severin SE, Shvets VI (2011). "Telomerase inhibitors as novel antitumour drugs". Applied Biochemistry and Microbiology. 47 (7): 655–660. doi:10.1134/S0003683811070039. S2CID 36207629.
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (February 2013). "Highly recurrent TERT promoter mutations in human melanoma". Science. 339 (6122): 957–9. Bibcode:2013Sci...339..957H. doi:10.1126/science.1229259. PMC 4423787. PMID 23348506.
Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M (April 2000). "Cytotoxic T cell immunity against telomerase reverse transcriptase in humans". Proceedings of the National Academy of Sciences of the United States of America. 97 (9): 4796–801. Bibcode:2000PNAS...97.4796M. doi:10.1073/pnas.070560797. PMC 18312. PMID 10759561.
Frolkis M, Fischer MB, Wang Z, Lebkowski JS, Chiu CP, Majumdar AS (March 2003). "Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors". Cancer Gene Therapy. 10 (3): 239–49. doi:10.1038/sj.cgt.7700563. PMID 12637945.
Vonderheide RH, Hahn WC, Schultze JL, Nadler LM (June 1999). "The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes". Immunity. 10 (6): 673–9. doi:10.1016/S1074-7613(00)80066-7. PMID 10403642.
Rosenberg SA (March 1999). "A new era for cancer immunotherapy based on the genes that encode cancer antigens". Immunity. 10 (3): 281–7. doi:10.1016/S1074-7613(00)80028-X. PMID 10204484.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.
Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, et al. (August 2009). "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells". Nature. 460 (7259): 1145–8. Bibcode:2009Natur.460.1145U. doi:10.1038/nature08285. PMC 3987892. PMID 19668190.
Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, et al. (May 2011). "Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells". Nature. 474 (7351): 399–402. doi:10.1038/nature10084. PMC 3155806. PMID 21602826.
Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, et al. (March 2010). "Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients". Nature. 464 (7286): 292–6. Bibcode:2010Natur.464..292A. doi:10.1038/nature08792. PMC 3058620. PMID 20164838.
Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS (September 2009). "Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells". Blood. 114 (11): 2236–43. doi:10.1182/blood-2008-09-178871. PMC 2745844. PMID 19561322.
Sahin E, Depinho RA (March 2010). "Linking functional decline of telomeres, mitochondria and stem cells during ageing". Nature. 464 (7288): 520–8. Bibcode:2010Natur.464..520S. doi:10.1038/nature08982. PMC 3733214. PMID 20336134.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, et al. (January 2011). "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice". Nature. 469 (7328): 102–6. Bibcode:2011Natur.469..102J. doi:10.1038/nature09603. PMC 3057569. PMID 21113150.
Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA (August 2012). "Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer". EMBO Molecular Medicine. 4 (8): 691–704. doi:10.1002/emmm.201200245. PMC 3494070. PMID 22585399.
Lu AT, Xue L, Salfati EL, Chen BH, Ferrucci L, Levy D, et al. (January 2018). "GWAS of epigenetic aging rates in blood reveals a critical role for TERT". Nature Communications. 9 (1): 387. Bibcode:2018NatCo...9..387L. doi:10.1038/s41467-017-02697-5. PMC 5786029. PMID 29374233.
Abdul-Ghani R, Ohana P, Matouk I, Ayesh S, Ayesh B, Laster M, et al. (December 2000). "Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells". Molecular Therapy. 2 (6): 539–44. doi:10.1006/mthe.2000.0196. PMID 11124054.
You Y, Geng X, Zhao P, Fu Z, Wang C, Chao S, et al. (March 2007). "Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts". Cellular and Molecular Life Sciences. 64 (5): 621–31. doi:10.1007/s00018-007-6424-4. PMC 11138417. PMID 17310280. S2CID 23250809.
Song JS, Kim HP, Yoon WS, Lee KW, Kim MH, Kim KT, et al. (November 2003). "Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line". Bioscience, Biotechnology, and Biochemistry. 67 (11): 2344–50. doi:10.1271/bbb.67.2344. PMID 14646192.
Jan HM, Wei MF, Peng CL, Lin SJ, Lai PS, Shieh MJ (January 2012). "The use of polyethylenimine-DNA to topically deliver hTERT to promote hair growth". Gene Therapy. 19 (1): 86–93. doi:10.1038/gt.2011.62. PMID 21593794.
Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S (February 2003). "Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation". FEBS Letters. 536 (1–3): 180–6. doi:10.1016/S0014-5793(03)00058-9. PMID 12586360. S2CID 26111467.
Kawauchi K, Ihjima K, Yamada O (May 2005). "IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells". Journal of Immunology. 174 (9): 5261–9. doi:10.4049/jimmunol.174.9.5261. PMID 15843522.
Chai W, Ford LP, Lenertz L, Wright WE, Shay JW (December 2002). "Human Ku70/80 associates physically with telomerase through interaction with hTERT". The Journal of Biological Chemistry. 277 (49): 47242–7. doi:10.1074/jbc.M208542200. PMID 12377759.
Song H, Li Y, Chen G, Xing Z, Zhao J, Yokoyama KK, et al. (April 2004). "Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length". Biochemical and Biophysical Research Communications. 316 (4): 1116–23. doi:10.1016/j.bbrc.2004.02.166. PMID 15044100.
Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, et al. (December 2004). "Nucleolin interacts with telomerase". The Journal of Biological Chemistry. 279 (49): 51508–15. doi:10.1074/jbc.M407643200. hdl:2297/15897. PMID 15371412.
Zhou XZ, Lu KP (November 2001). "The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor". Cell. 107 (3): 347–59. doi:10.1016/S0092-8674(01)00538-4. PMID 11701125. S2CID 6822193.
Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T (June 2000). "Involvement of 14-3-3 proteins in nuclear localization of telomerase". The EMBO Journal. 19 (11): 2652–61. doi:10.1093/emboj/19.11.2652. PMC 212742. PMID 10835362.
Sheng JF, Chen W, Yu Y, Liu J, Tao ZZ (December 2010). "PAR-4 and hTERT expression are negatively correlated after RNA interference targeting hTERT in laryngocarcinoma cells". Tissue & Cell. 42 (6): 365–9. doi:10.1016/j.tice.2010.08.002. PMID 20970818.

ensembl.org (Global: 1,626^th place; English: 1,007^th place)

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000164362 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000021611 – Ensembl, May 2017

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.
Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, et al. (December 2004). "Nucleolin interacts with telomerase". The Journal of Biological Chemistry. 279 (49): 51508–15. doi:10.1074/jbc.M407643200. hdl:2297/15897. PMID 15371412.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Shampay J, Blackburn EH (January 1988). "Generation of telomere-length heterogeneity in Saccharomyces cerevisiae". Proceedings of the National Academy of Sciences of the United States of America. 85 (2): 534–8. Bibcode:1988PNAS...85..534S. doi:10.1073/pnas.85.2.534. PMC 279585. PMID 3277178.
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (February 2013). "Highly recurrent TERT promoter mutations in human melanoma". Science. 339 (6122): 957–9. Bibcode:2013Sci...339..957H. doi:10.1126/science.1229259. PMC 4423787. PMID 23348506.
Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M (April 2000). "Cytotoxic T cell immunity against telomerase reverse transcriptase in humans". Proceedings of the National Academy of Sciences of the United States of America. 97 (9): 4796–801. Bibcode:2000PNAS...97.4796M. doi:10.1073/pnas.070560797. PMC 18312. PMID 10759561.
Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, et al. (August 2009). "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells". Nature. 460 (7259): 1145–8. Bibcode:2009Natur.460.1145U. doi:10.1038/nature08285. PMC 3987892. PMID 19668190.
Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, et al. (March 2010). "Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients". Nature. 464 (7286): 292–6. Bibcode:2010Natur.464..292A. doi:10.1038/nature08792. PMC 3058620. PMID 20164838.
Sahin E, Depinho RA (March 2010). "Linking functional decline of telomeres, mitochondria and stem cells during ageing". Nature. 464 (7288): 520–8. Bibcode:2010Natur.464..520S. doi:10.1038/nature08982. PMC 3733214. PMID 20336134.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, et al. (January 2011). "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice". Nature. 469 (7328): 102–6. Bibcode:2011Natur.469..102J. doi:10.1038/nature09603. PMC 3057569. PMID 21113150.
Lu AT, Xue L, Salfati EL, Chen BH, Ferrucci L, Levy D, et al. (January 2018). "GWAS of epigenetic aging rates in blood reveals a critical role for TERT". Nature Communications. 9 (1): 387. Bibcode:2018NatCo...9..387L. doi:10.1038/s41467-017-02697-5. PMC 5786029. PMID 29374233.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. (December 1997). "Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT". Nature Genetics. 17 (4): 498–502. doi:10.1038/ng1297-498. PMID 9398860. S2CID 2558116.
Kirkpatrick KL, Mokbel K (December 2001). "The significance of human telomerase reverse transcriptase (hTERT) in cancer". European Journal of Surgical Oncology. 27 (8): 754–60. doi:10.1053/ejso.2001.1151. PMID 11735173.
Shampay J, Blackburn EH (January 1988). "Generation of telomere-length heterogeneity in Saccharomyces cerevisiae". Proceedings of the National Academy of Sciences of the United States of America. 85 (2): 534–8. Bibcode:1988PNAS...85..534S. doi:10.1073/pnas.85.2.534. PMC 279585. PMID 3277178.
Poole JC, Andrews LG, Tollefsbol TO (May 2001). "Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)". Gene. 269 (1–2): 1–12. doi:10.1016/S0378-1119(01)00440-1. PMID 11376932.
Zhang A, Zheng C, Hou M, Lindvall C, Li KJ, Erlandsson F, et al. (April 2003). "Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome". American Journal of Human Genetics. 72 (4): 940–8. doi:10.1086/374565. PMC 1180356. PMID 12629597.
Cerruti Mainardi P (September 2006). "Cri du Chat syndrome". Orphanet Journal of Rare Diseases. 1: 33. doi:10.1186/1750-1172-1-33. PMC 1574300. PMID 16953888.
Cong YS, Wen J, Bacchetti S (January 1999). "The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter". Human Molecular Genetics. 8 (1): 137–42. doi:10.1093/hmg/8.1.137. PMID 9887342.
Bryce LA, Morrison N, Hoare SF, Muir S, Keith WN (2000). "Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization". Neoplasia. 2 (3): 197–201. doi:10.1038/sj.neo.7900092. PMC 1507564. PMID 10935505.
Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I (2008). "Telomerase regulation at the crossroads of cell fate". Cytogenetic and Genome Research. 122 (3–4): 263–72. doi:10.1159/000167812. PMID 19188695. S2CID 46652078.
Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.
Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, et al. (February 2009). "Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells". Cell Stem Cell. 4 (2): 141–54. doi:10.1016/j.stem.2008.12.010. PMID 19200803.
Walne AJ, Dokal I (April 2009). "Advances in the understanding of dyskeratosis congenita". British Journal of Haematology. 145 (2): 164–72. doi:10.1111/j.1365-2141.2009.07598.x. PMC 2882229. PMID 19208095.
Flores I, Benetti R, Blasco MA (June 2006). "Telomerase regulation and stem cell behaviour". Current Opinion in Cell Biology. 18 (3): 254–60. doi:10.1016/j.ceb.2006.03.003. PMID 16617011.
Calado R, Young N (2012). "Telomeres in disease". F1000 Medicine Reports. 4: 8. doi:10.3410/M4-8. PMC 3318193. PMID 22500192.
Flores I, Blasco MA (September 2010). "The role of telomeres and telomerase in stem cell aging". FEBS Letters. 584 (17): 3826–30. doi:10.1016/j.febslet.2010.07.042. PMID 20674573. S2CID 22993253.
Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT, Hung SC (July 2010). "Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines". Journal of Biomedical Science. 17 (1): 64. doi:10.1186/1423-0127-17-64. PMC 2923118. PMID 20670406.
Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, et al. (April 2006). "hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis". Cancer Research. 66 (7): 3531–40. doi:10.1158/0008-5472.CAN-05-2183. PMID 16585177.
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. (January 1998). "Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas". Nature Genetics. 18 (1): 65–8. doi:10.1038/ng0198-65. PMID 9425903. S2CID 8856414.
Elwood NJ, Jiang XR, Chiu CP, Lebkowski JS, Smith CA (March 2004). "Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase". Haematologica. 89 (3): 377–8. PMID 15020288.
Baird DM (May 2010). "Variation at the TERT locus and predisposition for cancer". Expert Reviews in Molecular Medicine. 12: e16. doi:10.1017/S146239941000147X. PMID 20478107. S2CID 13727556.
McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. (December 2008). "Lung cancer susceptibility locus at 5p15.33". Nature Genetics. 40 (12): 1404–6. doi:10.1038/ng.254. PMC 2748187. PMID 18978790.
Sundin T, Hentosh P (March 2012). "InTERTesting association between telomerase, mTOR and phytochemicals". Expert Reviews in Molecular Medicine. 14: e8. doi:10.1017/erm.2012.1. PMID 22455872. S2CID 8076416.
Zhang X, Mar V, Zhou W, Harrington L, Robinson MO (September 1999). "Telomere shortening and apoptosis in telomerase-inhibited human tumor cells". Genes & Development. 13 (18): 2388–99. doi:10.1101/gad.13.18.2388. PMC 317024. PMID 10500096.
Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. (June 2012). "Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis". Journal of the National Cancer Institute. 104 (11): 840–54. doi:10.1093/jnci/djs222. PMC 3611810. PMID 22523397.
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (February 2013). "Highly recurrent TERT promoter mutations in human melanoma". Science. 339 (6122): 957–9. Bibcode:2013Sci...339..957H. doi:10.1126/science.1229259. PMC 4423787. PMID 23348506.
Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M (April 2000). "Cytotoxic T cell immunity against telomerase reverse transcriptase in humans". Proceedings of the National Academy of Sciences of the United States of America. 97 (9): 4796–801. Bibcode:2000PNAS...97.4796M. doi:10.1073/pnas.070560797. PMC 18312. PMID 10759561.
Frolkis M, Fischer MB, Wang Z, Lebkowski JS, Chiu CP, Majumdar AS (March 2003). "Dendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumors". Cancer Gene Therapy. 10 (3): 239–49. doi:10.1038/sj.cgt.7700563. PMID 12637945.
Vonderheide RH, Hahn WC, Schultze JL, Nadler LM (June 1999). "The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes". Immunity. 10 (6): 673–9. doi:10.1016/S1074-7613(00)80066-7. PMID 10403642.
Rosenberg SA (March 1999). "A new era for cancer immunotherapy based on the genes that encode cancer antigens". Immunity. 10 (3): 281–7. doi:10.1016/S1074-7613(00)80028-X. PMID 10204484.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.
Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, et al. (August 2009). "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells". Nature. 460 (7259): 1145–8. Bibcode:2009Natur.460.1145U. doi:10.1038/nature08285. PMC 3987892. PMID 19668190.
Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, et al. (May 2011). "Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells". Nature. 474 (7351): 399–402. doi:10.1038/nature10084. PMC 3155806. PMID 21602826.
Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, et al. (March 2010). "Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients". Nature. 464 (7286): 292–6. Bibcode:2010Natur.464..292A. doi:10.1038/nature08792. PMC 3058620. PMID 20164838.
Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS (September 2009). "Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells". Blood. 114 (11): 2236–43. doi:10.1182/blood-2008-09-178871. PMC 2745844. PMID 19561322.
Sahin E, Depinho RA (March 2010). "Linking functional decline of telomeres, mitochondria and stem cells during ageing". Nature. 464 (7288): 520–8. Bibcode:2010Natur.464..520S. doi:10.1038/nature08982. PMC 3733214. PMID 20336134.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, et al. (January 2011). "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice". Nature. 469 (7328): 102–6. Bibcode:2011Natur.469..102J. doi:10.1038/nature09603. PMC 3057569. PMID 21113150.
Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA (August 2012). "Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer". EMBO Molecular Medicine. 4 (8): 691–704. doi:10.1002/emmm.201200245. PMC 3494070. PMID 22585399.
Lu AT, Xue L, Salfati EL, Chen BH, Ferrucci L, Levy D, et al. (January 2018). "GWAS of epigenetic aging rates in blood reveals a critical role for TERT". Nature Communications. 9 (1): 387. Bibcode:2018NatCo...9..387L. doi:10.1038/s41467-017-02697-5. PMC 5786029. PMID 29374233.
Abdul-Ghani R, Ohana P, Matouk I, Ayesh S, Ayesh B, Laster M, et al. (December 2000). "Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells". Molecular Therapy. 2 (6): 539–44. doi:10.1006/mthe.2000.0196. PMID 11124054.
Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL (June 2004). "[Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference]". AI Zheng = Aizheng = Chinese Journal of Cancer (in Chinese). 23 (6): 619–25. PMID 15191658.
You Y, Geng X, Zhao P, Fu Z, Wang C, Chao S, et al. (March 2007). "Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts". Cellular and Molecular Life Sciences. 64 (5): 621–31. doi:10.1007/s00018-007-6424-4. PMC 11138417. PMID 17310280. S2CID 23250809.
Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, et al. (2001). "FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo". Anticancer Research. 21 (3B): 1937–43. PMID 11497281.
Song JS, Kim HP, Yoon WS, Lee KW, Kim MH, Kim KT, et al. (November 2003). "Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line". Bioscience, Biotechnology, and Biochemistry. 67 (11): 2344–50. doi:10.1271/bbb.67.2344. PMID 14646192.
Jan HM, Wei MF, Peng CL, Lin SJ, Lai PS, Shieh MJ (January 2012). "The use of polyethylenimine-DNA to topically deliver hTERT to promote hair growth". Gene Therapy. 19 (1): 86–93. doi:10.1038/gt.2011.62. PMID 21593794.
Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S (February 2003). "Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation". FEBS Letters. 536 (1–3): 180–6. doi:10.1016/S0014-5793(03)00058-9. PMID 12586360. S2CID 26111467.
Kawauchi K, Ihjima K, Yamada O (May 2005). "IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells". Journal of Immunology. 174 (9): 5261–9. doi:10.4049/jimmunol.174.9.5261. PMID 15843522.
Chai W, Ford LP, Lenertz L, Wright WE, Shay JW (December 2002). "Human Ku70/80 associates physically with telomerase through interaction with hTERT". The Journal of Biological Chemistry. 277 (49): 47242–7. doi:10.1074/jbc.M208542200. PMID 12377759.
Song H, Li Y, Chen G, Xing Z, Zhao J, Yokoyama KK, et al. (April 2004). "Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length". Biochemical and Biophysical Research Communications. 316 (4): 1116–23. doi:10.1016/j.bbrc.2004.02.166. PMID 15044100.
Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, et al. (December 2004). "Nucleolin interacts with telomerase". The Journal of Biological Chemistry. 279 (49): 51508–15. doi:10.1074/jbc.M407643200. hdl:2297/15897. PMID 15371412.
Zhou XZ, Lu KP (November 2001). "The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor". Cell. 107 (3): 347–59. doi:10.1016/S0092-8674(01)00538-4. PMID 11701125. S2CID 6822193.
Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T (June 2000). "Involvement of 14-3-3 proteins in nuclear localization of telomerase". The EMBO Journal. 19 (11): 2652–61. doi:10.1093/emboj/19.11.2652. PMC 212742. PMID 10835362.
Sheng JF, Chen W, Yu Y, Liu J, Tao ZZ (December 2010). "PAR-4 and hTERT expression are negatively correlated after RNA interference targeting hTERT in laryngocarcinoma cells". Tissue & Cell. 42 (6): 365–9. doi:10.1016/j.tice.2010.08.002. PMID 20970818.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Shampay J, Blackburn EH (January 1988). "Generation of telomere-length heterogeneity in Saccharomyces cerevisiae". Proceedings of the National Academy of Sciences of the United States of America. 85 (2): 534–8. Bibcode:1988PNAS...85..534S. doi:10.1073/pnas.85.2.534. PMC 279585. PMID 3277178.
Zhang A, Zheng C, Hou M, Lindvall C, Li KJ, Erlandsson F, et al. (April 2003). "Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome". American Journal of Human Genetics. 72 (4): 940–8. doi:10.1086/374565. PMC 1180356. PMID 12629597.
Cerruti Mainardi P (September 2006). "Cri du Chat syndrome". Orphanet Journal of Rare Diseases. 1: 33. doi:10.1186/1750-1172-1-33. PMC 1574300. PMID 16953888.
"Entrez Gene: TERT telomerase reverse transcriptase".
Bryce LA, Morrison N, Hoare SF, Muir S, Keith WN (2000). "Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization". Neoplasia. 2 (3): 197–201. doi:10.1038/sj.neo.7900092. PMC 1507564. PMID 10935505.
Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.
Walne AJ, Dokal I (April 2009). "Advances in the understanding of dyskeratosis congenita". British Journal of Haematology. 145 (2): 164–72. doi:10.1111/j.1365-2141.2009.07598.x. PMC 2882229. PMID 19208095.
Calado R, Young N (2012). "Telomeres in disease". F1000 Medicine Reports. 4: 8. doi:10.3410/M4-8. PMC 3318193. PMID 22500192.
Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT, Hung SC (July 2010). "Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines". Journal of Biomedical Science. 17 (1): 64. doi:10.1186/1423-0127-17-64. PMC 2923118. PMID 20670406.
McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. (December 2008). "Lung cancer susceptibility locus at 5p15.33". Nature Genetics. 40 (12): 1404–6. doi:10.1038/ng.254. PMC 2748187. PMID 18978790.
Zhang X, Mar V, Zhou W, Harrington L, Robinson MO (September 1999). "Telomere shortening and apoptosis in telomerase-inhibited human tumor cells". Genes & Development. 13 (18): 2388–99. doi:10.1101/gad.13.18.2388. PMC 317024. PMID 10500096.
Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, et al. (June 2012). "Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis". Journal of the National Cancer Institute. 104 (11): 840–54. doi:10.1093/jnci/djs222. PMC 3611810. PMID 22523397.
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (February 2013). "Highly recurrent TERT promoter mutations in human melanoma". Science. 339 (6122): 957–9. Bibcode:2013Sci...339..957H. doi:10.1126/science.1229259. PMC 4423787. PMID 23348506.
Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M (April 2000). "Cytotoxic T cell immunity against telomerase reverse transcriptase in humans". Proceedings of the National Academy of Sciences of the United States of America. 97 (9): 4796–801. Bibcode:2000PNAS...97.4796M. doi:10.1073/pnas.070560797. PMC 18312. PMID 10759561.
Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, et al. (August 2009). "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells". Nature. 460 (7259): 1145–8. Bibcode:2009Natur.460.1145U. doi:10.1038/nature08285. PMC 3987892. PMID 19668190.
Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, et al. (May 2011). "Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells". Nature. 474 (7351): 399–402. doi:10.1038/nature10084. PMC 3155806. PMID 21602826.
Agarwal S, Loh YH, McLoughlin EM, Huang J, Park IH, Miller JD, et al. (March 2010). "Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients". Nature. 464 (7286): 292–6. Bibcode:2010Natur.464..292A. doi:10.1038/nature08792. PMC 3058620. PMID 20164838.
Calado RT, Yewdell WT, Wilkerson KL, Regal JA, Kajigaya S, Stratakis CA, Young NS (September 2009). "Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells". Blood. 114 (11): 2236–43. doi:10.1182/blood-2008-09-178871. PMC 2745844. PMID 19561322.
Sahin E, Depinho RA (March 2010). "Linking functional decline of telomeres, mitochondria and stem cells during ageing". Nature. 464 (7288): 520–8. Bibcode:2010Natur.464..520S. doi:10.1038/nature08982. PMC 3733214. PMID 20336134.
Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, et al. (January 2011). "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice". Nature. 469 (7328): 102–6. Bibcode:2011Natur.469..102J. doi:10.1038/nature09603. PMC 3057569. PMID 21113150.
Bernardes de Jesus B, Vera E, Schneeberger K, Tejera AM, Ayuso E, Bosch F, Blasco MA (August 2012). "Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer". EMBO Molecular Medicine. 4 (8): 691–704. doi:10.1002/emmm.201200245. PMC 3494070. PMID 22585399.
Lu AT, Xue L, Salfati EL, Chen BH, Ferrucci L, Levy D, et al. (January 2018). "GWAS of epigenetic aging rates in blood reveals a critical role for TERT". Nature Communications. 9 (1): 387. Bibcode:2018NatCo...9..387L. doi:10.1038/s41467-017-02697-5. PMC 5786029. PMID 29374233.
You Y, Geng X, Zhao P, Fu Z, Wang C, Chao S, et al. (March 2007). "Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts". Cellular and Molecular Life Sciences. 64 (5): 621–31. doi:10.1007/s00018-007-6424-4. PMC 11138417. PMID 17310280. S2CID 23250809.
Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T (June 2000). "Involvement of 14-3-3 proteins in nuclear localization of telomerase". The EMBO Journal. 19 (11): 2652–61. doi:10.1093/emboj/19.11.2652. PMC 212742. PMID 10835362.

nii.ac.jp (Global: 304^th place; English: 1,952^nd place)

kanazawa-u.repo.nii.ac.jp

Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. (December 1997). "Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT". Nature Genetics. 17 (4): 498–502. doi:10.1038/ng1297-498. PMID 9398860. S2CID 2558116.
Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I (2008). "Telomerase regulation at the crossroads of cell fate". Cytogenetic and Genome Research. 122 (3–4): 263–72. doi:10.1159/000167812. PMID 19188695. S2CID 46652078.
Kyo S, Takakura M, Fujiwara T, Inoue M (August 2008). "Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers". Cancer Science. 99 (8): 1528–38. doi:10.1111/j.1349-7006.2008.00878.x. hdl:2297/45975. PMC 11158053. PMID 18754863. S2CID 20774974.
Flores I, Blasco MA (September 2010). "The role of telomeres and telomerase in stem cell aging". FEBS Letters. 584 (17): 3826–30. doi:10.1016/j.febslet.2010.07.042. PMID 20674573. S2CID 22993253.
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. (January 1998). "Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas". Nature Genetics. 18 (1): 65–8. doi:10.1038/ng0198-65. PMID 9425903. S2CID 8856414.
Baird DM (May 2010). "Variation at the TERT locus and predisposition for cancer". Expert Reviews in Molecular Medicine. 12: e16. doi:10.1017/S146239941000147X. PMID 20478107. S2CID 13727556.
Sundin T, Hentosh P (March 2012). "InTERTesting association between telomerase, mTOR and phytochemicals". Expert Reviews in Molecular Medicine. 14: e8. doi:10.1017/erm.2012.1. PMID 22455872. S2CID 8076416.
Glukhov AI, Svinareva LV, Severin SE, Shvets VI (2011). "Telomerase inhibitors as novel antitumour drugs". Applied Biochemistry and Microbiology. 47 (7): 655–660. doi:10.1134/S0003683811070039. S2CID 36207629.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.
You Y, Geng X, Zhao P, Fu Z, Wang C, Chao S, et al. (March 2007). "Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts". Cellular and Molecular Life Sciences. 64 (5): 621–31. doi:10.1007/s00018-007-6424-4. PMC 11138417. PMID 17310280. S2CID 23250809.
Haendeler J, Hoffmann J, Rahman S, Zeiher AM, Dimmeler S (February 2003). "Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation". FEBS Letters. 536 (1–3): 180–6. doi:10.1016/S0014-5793(03)00058-9. PMID 12586360. S2CID 26111467.
Zhou XZ, Lu KP (November 2001). "The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor". Cell. 107 (3): 347–59. doi:10.1016/S0092-8674(01)00538-4. PMID 11701125. S2CID 6822193.

Telomerase reverse transcriptase (English Wikipedia)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 1,626th place; English: 1,007th place)